Table 2.
Glycan histo-blood groups (BGs) and selected disease associations.
| BG | Type | Disease susceptibility | Reference |
|---|---|---|---|
| ABO | O | H. pylori infection | [63] |
| E. coli O157 infection and death | [67] | ||
| Peptic ulcer | [68] | ||
| A | S. mansoni infection & disease severity | [69] | |
| Gastric cancer | [68] | ||
| Overall cancer | [70] | ||
| B | Salmonellosis | [71] | |
| E. Coli infection | [71] | ||
| Non-O | Severe malaria Exocrine pancreatic cancer Cardiovascular disease |
[72] [73] [74] |
|
| LE | Inactive | Urinary tract infections Invasive ductal breast carcinoma Childhood asthma |
[75] [76] [77] |
| Se | Inactive (non-Se) |
S. pneumonia infection N. meningitidis infection H. influenza infection Urinary tract infections Gram-negative sepsis in premature infants Necrotizing enterocolitis in premature infants Gastric disease Crohn's disease Primary sclerosing cholangitis Chronic pancreatitis Type 1 diabetes Breast axillary lymph nodes metastasis |
[78] [78] [79] [75] [80] [80] [81] [22], [82] [82] [21] [83] [76] |
| Active (Se) | Norovirus infection Rotavirus infection Influenza virus A & B infection Rhinovirus infection Respiratory syncytial virus infection Echovirus infection HIV infection and disease progression |
[84], [85], [86], [87] [88] [89] [89] [89] [89] [90] |